Very recently, JBI-802 has been identified as a dual LSD1/HDAC6/8 inhibitor, which displayed huge antiproliferative effects in SCLC and others haematological and solid tumours [135]. The gene discussed is KDM1A; the disease is small cell lung carcinoma.